H.I.G. Capital Sells Celerion to THL Partners
H.I.G. Capital has sold its portfolio company Celerion to THL Partners. Celerion is a global CRO specializing in clinical pharmacology and bioanalytical sciences. The sale follows H.I.G.'s investment since November 2022, which supported growth and expansion.
Tickers: $HIG
Topics: acquisition Celerion Holdings CRO H.I.G. Capital THL Partners